Through scientific discoveries, we are leading the way in Cannabis Therapeutics.
Helping to improve the lives of people in need.
Fotmer is the first fully licensed company in Uruguay producing top pharmaceutical grade cannabis flower (also known as Flos), Pharmaceutical Ingredients (API), cannabis extracts and manufactured products for the international market.
In October 2017, IRCCA (Institute for regulation & Cannabis Control) granted the Company a License for Cultivation, Harvest, Drying Stocking, Commercialize and Exporting of Psychoactive Cannabis.
We are strategically positioned to become the global leader in medical cannabis research, cultivation, processing and distribution. Our value chain is created from our expert knowledge and operational experience within medicinal cannabis.
The entire production process is designed to meet GMP (Good Manufacturing Practice) standards. Each one of our products is meticulously cared for to ensure the highest quality, consistency and purity.
Here at Fotmer we have identified the importance of scientific research. Specifically within medicinal cannabis becoming a approved medicine. We had partnered with leading researchers, hospitals and universities to advance the clinical applications of cannabinoids.
We produce medicinal grade products with standard active ingredient concentrations. This allows for precise formulations and consistent titration of active compounds.
Our standardized cannabis products are created with characterized genetics and certified chemical compositions using a traceable and fully GMP complaint processes.
Consumer products are available as dried flower. Full-spectrum extracts, formulated extracts, highly-purified cannabinoid isolates and blended active Pharmaceutical Ingredients (API) will be available for pharmaceutical drug development programs and commercial manufacturers.
Our consumer products are available as extracted and dried flower.
Each can be administered or consumed via a variety of methods.
Fotmer cultivates and produces a range
of dried cannabis products. They are
available as cured and trimmed whole
cannabis flower or precise blends
of ground cannabis.
The full spectrum of our products contain
extracted cannabis oil with full profile terpenes.
Our processes can also be tailored to
meet specific requirements.
State-of-the-art environmental technologies control all variables including light, temperature, air quality, nutrients and water within the facility. During the last year we have multiplied our cultivation area exponentially. This has allowed us to have a growing production big enough to supply the main markets of the world.
Current legislation seeks to position Uruguay as a leading supplier of medical cannabis for International markets. In 2013 Uruguay was the first country in the world to legalize and regulate cannabis including the commercialization, cultivation and distribution.
There is a competitive cost advantage due to Uruguay’s location and optimal growing conditions.
Latin America is becoming a leading cultivation center for global cannabis supply due its low-cost agricultural exports and increasing support for the legalization of cannabis.
The Latin American cultivation market offers a low-cost, high-quality alternative compared to Europe, Canada and Australia.
“Uruguay is a stable, prosperous democracy,
ranked first in the Economic Intelligence
Unit’s Latin American democracy index”
Towards Global Leadership
Our entire production process is built to meet the European Union’s Good Manufacturing Practice (EU-GMP) standards.